Diaph3 underlines tumor cell heterogeneity in glioblastoma with implications for treatment modalities resistance-Reference-Cited by-同舟云学术

Diaph3 underlines tumor cell heterogeneity in glioblastoma with implications for treatment modalities resistance

Published:2022-04-05 Issue:3 Volume:157 Page:523-531
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Stoyanov George S.^ORCID,Lyutfi Emran^ORCID,Georgieva Reneta,Georgiev Radoslav,Dzhenkov Deyan^ORCID,Petkova Lilyana,Ivanov Borislav D.^ORCID,Kaprelyan Ara^ORCID,Ghenev Peter

Funder

Medical Iniversity - Varna

National scientific fund - young researchers

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11060-022-03996-8.pdf

Reference44 articles.

1. Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251

2. Brat DJ, Aldape K, Colman H et al (2020) cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas. Acta Neuropathol 139:603–608

3. Volovetz J, Berezovsky AD, Alban T et al (2020) Identifying conserved molecular targets required for cell migration of glioblastoma cancer stem cells. Cell Death Dis 11:1–12

4. Tamimi AF, Juweid M (2017) Epidemiology and Outcome of Glioblastoma. In: De Vleeschouwer S (ed) Glioblastoma. Codon Publications, Brisbane, pp 143–153

5. Hara A, Kanayama T, Noguchi K et al (2019) Treatment strategies based on histological targets against invasive and resistant glioblastoma. J Oncol 2019:1–10

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a cisplatin resistant-based prognostic immune related gene signature in MIBC;Translational Oncology;2024-06

2. Comprehensive Analysis of the role of DIAPH3 in Cancers and Validation in Bladder Cancer;2023-03-15